News | October 05, 2009

UVA Uses MRgFUS to Treat Brain, Breast, Prostate, Bone, Liver Tumors

October 6, 2009 - At the University of Virginia Health System where they opened a new Magnetic Resonance Guided Focused Ultrasound Surgery Center, specialists are using magnetic resonance guided focused ultrasound (MRgFUS) to perform research that will represent a wide range of disciplines, including anesthesiology, biomedical engineering, gynecology, neurology, neurosurgery, oncology, radiology, radiation oncology surgery and urology.

Within coming months, research will focus on using MRgFUS to treat brain, breast, prostate, bone and liver tumors and conditions such as epilepsy, stroke, chronic pain, Parkinson's disease and essential tremor.

Neal F. Kassell, M.D., a professor of neurosurgery at the University of Virginia's School of Medicine believes that MRgFUS may be the most important therapeutic development since the scalpel.

During MRgFUS treatments, which are noninvasive and performed on an outpatient basis, patients lie on a table while doctors use the visual capabilities of magnetic resonance imaging to direct hundreds of individual and normally harmless sound waves at a single treatment point deep inside the body.

When ultrasound waves intersect the intense energy destroys tumor cells, and according to Alan H. Matsumoto, M.D. and chairman of UVA’s Department of Radiology and co-director of the new center, the technology is so precise that it can treat sites as small as a millimeter.

Treatments, which will become available in late October, will take about three hours. Side effects, if any, are typically minimal - minor cramping is most common - and patients can expect to feel well enough to resume daily activities almost immediately.

James M. Larner, M.D., director of UVA's Focused Ultrasound Center and chairman of the Department of Radiation Oncology, notes that focused ultrasound has the ability to destroy 100 percent of cancer cells, unlike chemotherapy, which kills only a certain percentage of malignant cells. Also, cancer cells cannot become resistant to focused ultrasound in contrast to chemotherapy. In addition, focused ultrasound has a rapid dosing drop off, meaning the technology concentrates high levels of heat on a target site but does not spill over to nearby healthy tissue, potentially causing damage or patient complications.

For more information: www.virginia.edu

Related Content

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Contrast Media | August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
Clarius Wireless Ultrasound Scanners Now Available With Advanced Features
News | Ultrasound Imaging | August 09, 2017
Clarius Mobile Health has released advanced features and options for its wireless handheld ultrasound scanner for...
MRI Reveals Striking Brain Differences in People with Genetic Autism

Example images for a control participant , a deletion carrier, and a duplication carrier. In the sagittal image of the deletion carrier, the thick corpus callosum, dens and craniocervical abnormality, and cerebellar ectopia are shown. For the duplication carrier, the sagittal image shows the thin corpus callosum and the axial image shows the increased ventricle size and decreased white matter volume. Image courtesy of the Radiological Society of North America (RSNA).

News | Neuro Imaging | August 09, 2017
August 9, 2017 — In the first major study of its kind, researchers using magnetic...
Oregon Tech Partners with Mindray for High-Tech Ultrasound Education
News | Ultrasound Imaging | August 04, 2017
To better prepare its ultrasound students to compete and thrive in the evolving healthcare environment, Oregon...
GE Healthcare's Signa Premier MRI Receives FDA 510(k) Clearance
Technology | Magnetic Resonance Imaging (MRI) | August 04, 2017
GE Healthcare announced Signa Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Carestream Shows Touch Prime Systems at Society for Vascular Ultrasound Conference
News | Ultrasound Imaging | August 03, 2017
Carestream will showcase its Carestream Touch Prime and Touch Prime XE Ultrasound Systems at the Society for Vascular...
brain with chronic traumatic injury
News | Magnetic Resonance Imaging (MRI) | August 02, 2017
Fighters are exposed to repeated mild traumatic brain injury (mTBI), which has been associated with neurodegenerative...
Overlay Init